Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
21 Oct 2018
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
The past, present and future of treating ovarian cancer
Olaparib improves progression free survival up front in ovarian cancer
A novel bifunctional fusion protein for combatting lung cancer
Early stage trials in immunotherapy and brain screening
Results from the IMpassion130 trial for triple-negative breast cancer
Rare EGFR mutations in lung adenocarcinoma
New therapeutic options in advanced and metastatic breast cancer
Latest concepts in the diagnosis of genetic ALL subtypes
Can we reduce the intensity of frontline therapy?
Novel therapies for paediatric B-ALL
Management of MLL-rearranged ALL